Scientists track origins of multiple sclerosis

Scientists track origins of multiple sclerosis

The autoimmune response that is involved in multiple sclerosis (MS) was once thought to be confined to the brain. Yale researchers, however, have uncovered evidence that this damaging response may begin in the lymph nodes. 

The finding, reported in the issue of journal Science Translational Medicine, tracks the origin of the autoimmune response in the lymph nodes and later its arrival in the brain, where it contributes to tissue damage that results in numbness, loss of vision, and debilitating fatigue.

"This helps explain why treatments that work outside the central nervous system can ease MS symptoms and may give us clues how to develop even more effective treatments," said neuroimmunologist Kevin O'Connor, one of the senior authors of the paper. 

More information: B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes, Sci Transl Med 6 August 2014: Vol. 6, Issue 248, p. 248ra107 Sci. Transl. Med. DOI: 10.1126/scitranslmed.3008879

add to favorites email to friend print save as pdf

Related Stories

Researchers implicate unique cell type in multiple sclerosis

Aug 01, 2012

Researchers at the National Institutes of Health have found evidence that a unique type of immune cell contributes to multiple sclerosis (MS). Their discovery helps define the effects of one of the newest drugs under investigation ...

Novel immune target identified in multiple sclerosis

Jul 12, 2012

(HealthDay) -- About half of a subgroup of patients with multiple sclerosis have autoantibodies to a potassium channel in the brain, according to a study published in the July 12 issue of the New England Jo ...

Immune response may cause harm in brain injuries, disorders

Jul 24, 2014

Could the body's own immune system play a role in memory impairment and cognitive dysfunction associated with conditions like chronic epilepsy, Alzheimer's dementia and concussions? Cleveland Clinic researchers believe so, ...

Cancer drug a possible treatment for multiple sclerosis

Feb 21, 2013

(Medical Xpress)—A drug that is currently used for cancer can relieve and slow down the progression of the autoimmune disease multiple sclerosis (MS) in rats, according to a new study published in PLOS ONE. The discovery, which ...

Recommended for you

Research reveals how lymph nodes expand during disease

5 hours ago

Cancer Research UK and UCL scientists have discovered that the same specialised immune cells that patrol the body and spot infections also trigger the expansion of immune organs called lymph nodes, according to a study published ...

Protecting us from our cells

9 hours ago

Our immune system defends us from harmful bacteria and viruses, but, if left unchecked, the cells that destroy those invaders can turn on the body itself, causing auto-immune diseases like type-1 diabetes ...

User comments